Evidence map›Paper›PMID 41536155›Full record

ArticlePathology international2026

Extracting Histologic Features to Distinguish Primary and Metastatic Squamous Cell Carcinoma of the Lung.

Yuri Tachibana, Andrey Bychkov, Kris Lami, Jijgee Munkhdelger, Hoa Pham, Thiyaphat Laohawetwanit, Zun Pwint Oo, Izumi Sato, Luka Brcic, Junya Fukuoka

Abstract read
In one paragraph

Article in Pathology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuri TachibanaDepartment of Pathology Informatics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Andrey BychkovDepartment of Pathology, Kameda Medical Center, Chiba, Japan.ORCID https://orcid.org/0000-0002-4203-5696
Kris LamiDepartment of Pathology Informatics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Jijgee MunkhdelgerDepartment of Pathology, Kameda Medical Center, Chiba, Japan.
Hoa PhamDepartment of Medical Laboratory, Hospital of University of Medicine and Pharmacy, Linh Dam, Hanoi.
Thiyaphat LaohawetwanitChulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand.ORCID https://orcid.org/0000-0003-3805-7291
Zun Pwint OoDepartment of Pathology, University of Medicine, Mandalay, Myanmar.
Izumi SatoDepartment of Clinical Epidemiology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Luka BrcicDepartment of Pathology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-9098-8416
Junya FukuokaDepartment of Pathology Informatics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.ORCID https://orcid.org/0000-0002-2496-3050

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung is a common site of metastasis for squamous cell carcinoma (SqCC), and distinguishing primary lung SqCC from pulmonary metastatic SqCC is critical for clinical decision-making, including treatment planning. However, no practical histological criteria have been established for routine diagnosis. This study aimed to develop histopathological criteria to differentiate lung SqCC and pulmonary metastatic SqCC. A total of 85 surgical cases (48 primary and 37 metastatic) were collected with clinical background data. Seven histological features were evaluated. Six [morphological heterogeneity, dilated airway, interstitial fibrosis (IF), squamous dysplasia (SD), emphysema, RB macrophage] were presented as primary-associated features, while stromal infarction was proposed as metastatic. Seven pathologists scored these features. Primary-associated findings showed significantly higher score in primary cases. Tumor size (size) was significantly larger in the primary group (median: primary, 30 mm; metastatic, 14 mm; p < 0.001). A multivariate analysis incorporating size produced the "pathological primary formula" based on parameter estimates: 0.70・IF + 0.36・SD + 0.09・size, with an AUC of 0.86, sensitivity of 89.5%, and specificity of 70.2%. These results suggest that the extracted histologic features may provide reproducible criteria for distinguishing primary lung SqCC from pulmonary metastatic SqCC, offering insight into potential diagnostic applications.

Indexed as

Carcinoma, Squamous CellLung NeoplasmsAdultAgedAged, 80 and overDiagnosis, DifferentialFemaleHumansMaleMiddle Ageddiagnostic formulainterstitial fibrosislung squamous cell carcinomaprimary versus metastasissquamous dysplasia

Identifiers

PMID41536155
PMCPMC12835960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.